Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases.
about
Mouse and human eosinophils degranulate in response to platelet-activating factor (PAF) and lysoPAF via a PAF-receptor-independent mechanism: evidence for a novel receptorHigh-level production, solubilization and purification of synthetic human GPCR chemokine receptors CCR5, CCR3, CXCR4 and CX3CR1Effects of a dual CCR3 and H1-antagonist on symptoms and eosinophilic inflammation in allergic rhinitisNovel approach to inhibit asthma-mediated lung inflammation using anti-CD147 intervention.T lymphocytes expressing CCR3 are increased in allergic rhinitis compared with non-allergic controls and following allergen immunotherapyPharmacotherapy of asthma.Periprostatic adipocytes act as a driving force for prostate cancer progression in obesityThe mast cell and allergic diseases: role in pathogenesis and implications for therapy.Chemotaxis of bone marrow derived eosinophils in vivo: a novel method to explore receptor-dependent trafficking in the mouse.Epithelial cell-derived IL-25, but not Th17 cell-derived IL-17 or IL-17F, is crucial for murine asthmaDifferential serum levels of eosinophilic eotaxins in primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis.CC-chemokine CCL15 expression and possible implications for the pathogenesis of IgE-related severe asthma.Tyrosine sulfation is prevalent in human chemokine receptors important in lung disease.A new compound, 1H,8H-pyrano[3,4-c]pyran-1,8-dione, suppresses airway epithelial cell inflammatory responses in a murine model of asthma.Cloning, expression, and functional characterization of cynomolgus monkey (Macaca fascicularis) CC chemokine receptor 1.CXCL13 and CCL11 Serum Levels and Lymphoma and Disease Activity in Primary Sjögren's Syndrome.Attenuation of allergic airway inflammation in a murine model of asthma by Licochalcone A.CCL26-targeted siRNA treatment of alveolar type II cells decreases expression of CCR3-binding chemokines and reduces eosinophil migration: implications in asthma therapyHeligmosomoides polygyrus infection down-regulates eotaxin concentration and CCR3 expression on lung eosinophils in murine allergic pulmonary inflammation.Interplay between signaling via the formyl peptide receptor (FPR) and chemokine receptor 3 (CCR3) in human eosinophils.Histological and immunological features of non-eosinophilic nasal polyps.Functional expression of CCL8 and its interaction with chemokine receptor CCR3.Selective suppression of Th2-mediated airway eosinophil infiltration by low-molecular weight CCR3 antagonists.Chemokine CCL18 predicts intraventricular hemorrhage in very preterm infants.
P2860
Q24629279-382EFAE9-4C5F-41B8-AE17-0FD591241CD9Q28474776-B71849EB-F338-4B00-BEFF-E7D48CBD79F7Q33707735-F51B7313-A029-403E-8D15-99AA9BCBFA15Q33792231-DBFDC6B6-5C73-450C-BD70-963A85A25112Q36064562-2E4E47B2-7829-4BFA-8AD9-E4B16D1A0315Q36119936-D5081508-1EFF-4CBF-A273-7E53F2AB1B1BQ36511320-706CCFAB-09BF-464D-90D2-A1539EB5463DQ37010493-32FC8A4A-9078-4582-8ED3-BBBDC251A831Q37205226-571B1E91-7AA8-477C-B894-9326904715A6Q37265340-292D2ECE-455B-4BBE-96FE-B3C67A19388FQ37617640-4FDA9A27-285A-4143-A62F-292367B46203Q38069151-63AC9D61-D86B-4E89-8D53-0451E1CCA3C3Q38620316-4C8B9384-ABBD-402C-8A02-FFEA4C7C2FC6Q39788538-1549B2DE-7071-4D2F-A9D4-4F99FEFDCF63Q40365547-DA3A27B1-7908-4052-B07D-AEAC54691B39Q40550187-6E80A9F1-F213-4E15-BF51-39D3A0DD2CD9Q42248038-FFFA51BF-630F-4332-948F-68B8CA6B47C8Q42425233-7F196B0E-A08A-4E5C-80DB-38CB804D6C38Q44139904-A477CD0C-35EF-416D-AA2F-A2155A63E458Q46025968-251CCAFF-3B7A-4D7E-AE51-4DBC48AD1DC6Q46883873-450ABF75-C0DD-4636-B41C-5A1F6978CC9CQ47119819-8C0E9249-19C4-480B-BFDF-35988B691FFCQ47271733-BF7E31C3-EF6F-42D9-965C-41E8F1980606Q48137528-F4FFAD31-EF34-4145-B332-3ACB8A07D354
P2860
Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases.
@ast
Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases.
@en
type
label
Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases.
@ast
Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases.
@en
prefLabel
Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases.
@ast
Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases.
@en
P2093
P2860
P1433
P1476
Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases.
@en
P2093
P2860
P304
P356
10.1111/J.1398-9995.2004.00710.X
P577
2004-12-01T00:00:00Z